Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis

Summary

OBJECTIVES: I. Compare the safety and efficacy of monolaurin cream versus a placebo vehicle cream in suppressing the signs of nonbullous congenital ichthyosiform erythroderma. II. Assess the incidence of posttreatment rebound or recrudescence in patients with congenital ichthyosis. III. Evaluate the long term safety of monolaurin cream with whole body application in these patients.

Timeline

Start

1996-09

Primary completion

—

Completion

1998-09

Drugs

Indications